epigallocatechin gallate has been researched along with Osteogenic Sarcoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, C; Shen, P; Wang, H; Wang, J; Wang, Z | 1 |
| Bose, S; Kushram, P; Majumdar, U | 1 |
| Chen, D; Wang, W; Zhu, K | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| He, A; He, X; Jiang, L; Tao, C | 1 |
| Chen, B; Chen, J; Chen, X; Chen, Y; Qian, H; Tang, G; Wang, Y; Zhang, Z | 1 |
| Li, Q; Zhang, X | 1 |
| Wang, W; Zhu, K | 1 |
| Ender, SA; Hönicke, AS; Radons, J | 1 |
| Chan, K; Feng, WY; Johnston, J; Naasani, I; Oh-Hara, T; Oh-Hashi, F; Tsuruo, T | 1 |
| Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Campbell, KJ; O'Shea, JM; Perkins, ND | 1 |
| Han, DH; Ji, SJ; Kim, JH | 1 |
13 other study(ies) available for epigallocatechin gallate and Osteogenic Sarcoma
| Article | Year |
|---|---|
Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.
Topics: Animals; Apoptosis; beta Catenin; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Wnt Signaling Pathway | 2022 |
Hydroxyapatite coated titanium with curcumin and epigallocatechin gallate for orthopedic and dental applications.
Topics: Anti-Bacterial Agents; Bone Neoplasms; Curcumin; Durapatite; Humans; Osteosarcoma; Titanium | 2023 |
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Doxorubicin; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Neoplastic Stem Cells; Osteosarcoma; Receptor, Notch3; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2018 |
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Catechin; Cell Line, Tumor; Child; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Osteosarcoma; Pediatrics; Rhabdomyosarcoma; Sarcoma; Tumor Necrosis Factor-alpha | 2014 |
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
Topics: Apoptosis; Bone Neoplasms; Catechin; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; MicroRNAs; Osteosarcoma; Tumor Cells, Cultured | 2014 |
(-)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells.
Topics: Bone Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Osteosarcoma | 2015 |
Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model.
Topics: Animals; Behavior, Animal; Bone Neoplasms; Catechin; Disease Progression; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Osteosarcoma; Pain Measurement; Pain, Intractable; Spinal Cord; Spine; Tumor Necrosis Factor-alpha | 2015 |
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.
Topics: Apoptosis; Catechin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Crizotinib; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Osteosarcoma; Polyphenols; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Tea | 2016 |
Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells.
Topics: Antineoplastic Agents; Caspase 3; Catechin; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Drug Synergism; Enzyme Activation; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Interleukin-8; Matrix Metalloproteinase 2; Osteosarcoma; Receptors, Interleukin-1; Vascular Endothelial Growth Factor A | 2012 |
Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Colonic Neoplasms; Enzyme Inhibitors; Female; Flavonoids; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Phenols; Polymers; Telomerase; Tumor Cells, Cultured; U937 Cells; Xenograft Model Antitumor Assays | 2003 |
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Catechin; Cell Line, Tumor; Daunorubicin; DNA Damage; Doxorubicin; Enzyme Inhibitors; Free Radicals; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Intercalating Agents; Mitoxantrone; NF-kappa B; Osteosarcoma; Oxidation-Reduction; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors; Transcription, Genetic | 2006 |
Inhibition of proliferation and induction of apoptosis by EGCG in human osteogenic sarcoma (HOS) cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Catechin; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Osteosarcoma | 2006 |